Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06512701
What this trial is testing

Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFat Soluble Vitamin Deficiencies and Disorders
First Affiliated Hospital of Zhejiang University 4,000
Not applicableEnded earlyNCT01289639
What this trial is testing

Insulin Resistance in Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
VA Office of Research and Development 11
Testing effectiveness (Phase 2)Study completedNCT06104319
What this trial is testing

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 61
Post-approval studies (Phase 4)Enrolling By InvitationNCT05195944
What this trial is testing

Semaglutide vs Sitagliptin

Who this might be right for
Liver Transplant; ComplicationsDiabetes MellitusNASH - Nonalcoholic Steatohepatitis+1 more
University Health Network, Toronto 58
Early research (Phase 1)Study completedNCT02808312
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)
Gilead Sciences 57
Early research (Phase 1)WithdrawnNCT05203367
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BAR 502 in Healthy Subjects

Who this might be right for
Non-Alcoholic Fatty Liver Disease
BAR Pharmaceuticals s.r.l.
Not applicableStudy completedNCT03778411
What this trial is testing

Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

Who this might be right for
Advanced Chronic Liver Disease, NASH
Indiana University 298
Not applicableStudy completedNCT01997424
What this trial is testing

Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Johann Wolfgang Goethe University Hospital 340
Not applicableStudy completedNCT07378280
What this trial is testing

Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD

Who this might be right for
Non Alcoholic Fatty Liver Disease
Chuncheon Sacred Heart Hospital 95
Not applicableStudy completedNCT04579874
What this trial is testing

Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisLiver Fibroses+2 more
Fibronostics USA, Inc 241
Not applicableUnknownNCT03467282
What this trial is testing

Probiotics in NASH Patients - PROBILIVER TRIAL

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Hospital de Clinicas de Porto Alegre 46
Not applicableStudy completedNCT03294850
What this trial is testing

Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery

Who this might be right for
NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease
AdventHealth Translational Research Institute 14
Not applicableStudy completedNCT07580482
What this trial is testing

The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate Referral

Who this might be right for
Liver DiseasesLiver FatDiabetes Mellitus, Type 2+1 more
University of Kansas Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00590161
What this trial is testing

Pentoxifylline in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Case Western Reserve University 55
Very early researchStudy completedNCT05552274
What this trial is testing

FTIH of ECC4703 in Healthy Volunteers

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Eccogene 75
Testing effectiveness (Phase 2)Study completedNCT03118310
What this trial is testing

Treatment of NAFLD With Two Different Diets

Who this might be right for
NAFLD
Karolinska University Hospital 74
Not applicableStudy completedNCT05416970
What this trial is testing

The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University of Campania Luigi Vanvitelli 122
Large-scale testing (Phase 3)Study completedNCT00244569
What this trial is testing

Development of a Breath Test for Monitoring Patients With Liver Disease

Who this might be right for
Fatty LiverCirrhosis
Virginia Commonwealth University 120
Not applicableStudy completedNCT02181270
What this trial is testing

Changes in Intrahepatic Lipids With Exercise

Who this might be right for
Obese
University of Missouri-Columbia 57
Not applicableStudy completedNCT03060694
What this trial is testing

Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness Measurements

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 58
Next Page